331 related articles for article (PubMed ID: 25310347)
1. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
[TBL] [Abstract][Full Text] [Related]
2. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
[TBL] [Abstract][Full Text] [Related]
3. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.
Wilkins MR; Khan S; Bunce C; Khawaja A; Siriwardena D; Larkin DF
Br J Ophthalmol; 2011 Sep; 95(9):1299-303. PubMed ID: 21252084
[TBL] [Abstract][Full Text] [Related]
4. Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
Liu SH; Hawkins BS; Ng SM; Ren M; Leslie L; Han G; Kuo IC
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013520. PubMed ID: 35238405
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.
Shiuey Y; Ambati BK; Adamis AP
Ophthalmology; 2000 Aug; 107(8):1512-7. PubMed ID: 10919900
[TBL] [Abstract][Full Text] [Related]
6. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
7. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO
Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917
[TBL] [Abstract][Full Text] [Related]
8. Artificial tears alone versus 0.45% ketorolac tromethamine with artificial tears for the treatment of acute viral conjunctivitis.
Lyra AF; Bastos LC; Lima RC; Maranhão Lde V; Arantes TE
Arq Bras Oftalmol; 2014 Apr; 77(2):99-102. PubMed ID: 25076474
[TBL] [Abstract][Full Text] [Related]
9. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
Koçluk Y; Sukgen EA; Cevher S; Mat E
Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a Single Administration of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis.
Than T; Morettin CE; Harthan JS; Hartwick ATE; Huecker JB; Johnson SD; Migneco MK; Shorter E; Whiteside M; Olson CK; Alferez CS; van Zyl T; Rodic-Polic B; Storch GA; Gordon MO
Am J Ophthalmol; 2021 Nov; 231():28-38. PubMed ID: 34102153
[TBL] [Abstract][Full Text] [Related]
13. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
Özen Tunay Z; Ozdemir O; Petricli IS
Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.
Shorter E; Whiteside M; Harthan J; Margolis MS; Hartwick AT; Johnson S; Migneco M; Morettin C; Olson CK; Huecker J; Than T; Gordon MO
Ocul Surf; 2019 Oct; 17(4):828-832. PubMed ID: 31401340
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
Bhargava R; Kumar P
Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
[TBL] [Abstract][Full Text] [Related]
16. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
[TBL] [Abstract][Full Text] [Related]
17. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820
[TBL] [Abstract][Full Text] [Related]
18. Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease.
Moore QL; De Paiva CS; Pflugfelder SC
Am J Ophthalmol; 2015 Jul; 160(1):135-42.e1. PubMed ID: 25868759
[TBL] [Abstract][Full Text] [Related]
19. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.
Frucht-Pery J; Siganos CS; Solomon A; Shvartzenberg T; Richard C; Trinquand C
Am J Ophthalmol; 1999 Feb; 127(2):148-52. PubMed ID: 10030555
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
